By William Fitzgerald, MD Anderson Staff Writer
Seven years ago, Suzanne Hebert was diagnosed with metastatic breast
cancer that spread to her liver and bones. After four rounds of
chemotherapy and decreasing response rates, she decided it was time for a
change. That change came after advice from a friend, who also had
advanced breast cancer, and was enrolled on a clinical trial at MD
Anderson.
The trial combined two drugs, everolimus, and a hormone therapy
called arimidex. A different trial named BOLERO-2, or Breast Cancer
Trials of Oral Everolimus, showed that combining everolimus with a
different hormone therapy, exemestane, dramatically improved
progression-free survival for women with advanced breast cancer.
This week, the BOLERO-2 study was presented at the San Antonio
Breast Cancer Symposium by Gabriel Hortobagyi, M.D., professor and chair
of the Department of Breast Medical Oncology at MD Anderson.
In the below video, Hebert shares her story from diagnosis through
treatment. To learn more about the BOLERO-2 trial, read Combination Drug Therapy Promising for Advanced Breast Cancer.
BOLERO-2 Trial Offers Hope to Patients With Advanced Breast Cancer
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- How You Can Help
- Children's Art Project
- Directory
- Contact Us
- Sitemap
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Clinical Trials
- News and Publications
- Newsroom
- Publications
- Education and Research
- Departments, Programs & Labs
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- State of Texas
- State of Texas Home Page
- Statewide Search (TRAIL)
- State Comptroller - Where the Money Goes
- Texas Homeland Security
- The University of Texas System
- Institution Resume
- Legal and Policy
- Legal Statements & Site Policies
- Stay Connected
- Emergency Alerts
- Emergency Alert Information
© 2013 The University of Texas MD Anderson Cancer Center
Leave a comment